Reuters logo
BRIEF-Corline Biomedical: heparin substance granted orphan-drug designation by FDA
May 4, 2017 / 7:33 AM / in 7 months

BRIEF-Corline Biomedical: heparin substance granted orphan-drug designation by FDA

May 4 (Reuters) - CORLINE BIOMEDICAL AB

* NOTIFIED BY US FOOD AND DRUG ADMINISTRATION, FDA, THAT THE COMPANY‘S HEPARIN SUBSTANCE HAS BEEN GRANTED ORPHAN-DRUG DESIGNATION IN THE UNITED STATES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below